Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Current Assets (2020 - 2025)

Agilon Health's Current Assets history spans 6 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Current Assets fell 24.77% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, down 24.77%, while the annual FY2025 figure was $1.1 billion, 24.77% down from the prior year.
  • Current Assets reached $1.1 billion in Q4 2025 per AGL's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $2.0 billion in Q2 2023 to a low of $417.6 million in Q1 2021.
  • Average Current Assets over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2022.
  • Peak YoY movement for Current Assets: surged 364.72% in 2021, then fell 26.15% in 2025.
  • A 5-year view of Current Assets shows it stood at $1.4 billion in 2021, then increased by 6.15% to $1.5 billion in 2022, then rose by 1.98% to $1.5 billion in 2023, then fell by 1.51% to $1.5 billion in 2024, then decreased by 24.77% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Current Assets are $1.1 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.5 billion (Q2 2025).